0001209191-20-030482.txt : 20200519 0001209191-20-030482.hdr.sgml : 20200519 20200519162944 ACCESSION NUMBER: 0001209191-20-030482 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20894034 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2020-05-15 4 S 0 1 274.67 D 35160 D Common Stock 2020-05-15 4 S 0 3 276.21 D 35157 D Common Stock 2020-05-15 4 S 0 1 278.42 D 35156 D Common Stock 2020-05-15 4 S 0 10 280.34 D 35146 D Common Stock 2020-05-15 4 S 0 2 281.65 D 35144 D Common Stock 2020-05-15 4 S 0 5 283.01 D 35139 D Common Stock 2020-05-15 4 S 0 6 284.95 D 35133 D Common Stock 2020-05-15 4 S 0 11 286.63 D 35122 D Common Stock 2020-05-15 4 S 0 13 287.65 D 35109 D Common Stock 2020-05-15 4 S 0 6 288.36 D 35103 D Common Stock 882 I 401(k) Common Stock 14002 I GRAT Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $276.21 (range $275.87 to $276.44). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.91 to $280.73). Open market sales reported on this line occurred at a weighted average price of $281.65 (range $281.24 to $282.06). Open market sales reported on this line occurred at a weighted average price of $283.01 (range $282.71 to $283.40). Open market sales reported on this line occurred at a weighted average price of $284.95 (range $284.37 to $285.35). Open market sales reported on this line occurred at a weighted average price of $286.63 (range $286.14 to $287.12). Open market sales reported on this line occurred at a weighted average price of $287.65 (range $287.22 to $288.19). Open market sales reported on this line occurred at a weighted average price of $288.36 (range $288.23 to $288.47). /s/ Sabrina Yohai, Attorney-in-Fact 2020-05-19